Hemab Therapeutics Holdings, Inc. (COAG)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-21) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | — |
|
| Statements | ||
| Condensed Consolidated Balance Sheets | — |
|
| Condensed Consolidated Balance Sheets (P) | — |
|
| Condensed Consolidated Statements of Operations and Comprehensive Loss | — |
|
| Condensed Consolidated Statements of Changes In Convertible Preference Shares, Convertible Preferred Stock and Stockholders' Deficit | — |
|
| Condensed Consolidated Statements of Cash Flows | — |
|
| Notes | ||
| Accrued Expenses and Other Current Liabilities | — |
|
| Available-for-sale Debt Securities | — |
|
| Commitments and Contingencies | — |
|
| Common Stock and Ordinary Shares | — |
|
| Convertible Preferred Stock and Convertible Preference Shares | — |
|
| Description of Business and Liquidity | — |
|
| Equity-based Compensation | — |
|
| Fair Value Measurements | — |
|
| Insider Trading Arrangements | — |
|
| Net Loss Per Share | — |
|
| Pay Vs Performance Disclosure | — |
|
| Prepaid Expenses and Other Current Assets | — |
|
| Property and Equipment, Net | — |
|
| Segment Reporting | — |
|
| Subsequent Events | — |
|
| Summary of Significant Accounting Policies | — |
|